Cryo-Cell International, Inc. (CCEL)
USD 7.65
(-4.26%)
USD 7.65
(-4.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 61.22 Million USD | -5.65% |
| 2022 | 64.88 Million USD | 6.97% |
| 2021 | 60.66 Million USD | 31.3% |
| 2020 | 46.2 Million USD | 7.73% |
| 2019 | 42.88 Million USD | 1.17% |
| 2018 | 42.39 Million USD | 77.29% |
| 2017 | 23.9 Million USD | 22.37% |
| 2016 | 19.53 Million USD | 0.21% |
| 2015 | 19.49 Million USD | 90.98% |
| 2014 | 10.2 Million USD | -11.23% |
| 2013 | 11.5 Million USD | -6.73% |
| 2012 | 12.33 Million USD | -36.66% |
| 2011 | 19.46 Million USD | 7.18% |
| 2010 | 18.16 Million USD | 24.33% |
| 2009 | 14.6 Million USD | 33.13% |
| 2008 | 10.97 Million USD | -5.68% |
| 2007 | 11.63 Million USD | -20.54% |
| 2006 | 14.64 Million USD | 2.86% |
| 2005 | 14.23 Million USD | 22.27% |
| 2004 | 11.64 Million USD | 61.29% |
| 2003 | 7.21 Million USD | -47.94% |
| 2002 | 13.86 Million USD | -20.3% |
| 2001 | 17.39 Million USD | 111.16% |
| 2000 | 8.23 Million USD | 49.77% |
| 1999 | 5.5 Million USD | 34.15% |
| 1998 | 4.1 Million USD | 2.5% |
| 1997 | 4 Million USD | -4.76% |
| 1996 | 4.2 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 61.71 Million USD | 0.8% |
| 2024 Q3 | 62.93 Million USD | 0.59% |
| 2024 Q2 | 62.56 Million USD | 1.39% |
| 2023 FY | 61.22 Million USD | -5.65% |
| 2023 Q2 | 68.75 Million USD | 3.97% |
| 2023 Q4 | 61.22 Million USD | -12.29% |
| 2023 Q1 | 66.13 Million USD | 1.92% |
| 2023 Q3 | 69.79 Million USD | 1.51% |
| 2022 Q4 | 64.88 Million USD | -2.81% |
| 2022 Q3 | 66.76 Million USD | 20.53% |
| 2022 Q1 | 54.8 Million USD | -9.65% |
| 2022 Q2 | 55.39 Million USD | 1.07% |
| 2022 FY | 64.88 Million USD | 6.97% |
| 2021 Q3 | 59.42 Million USD | 1.9% |
| 2021 FY | 60.66 Million USD | 31.3% |
| 2021 Q1 | 105.26 Million USD | 127.84% |
| 2021 Q2 | 58.31 Million USD | -44.6% |
| 2021 Q4 | 60.66 Million USD | 2.08% |
| 2020 Q1 | 44.73 Million USD | 4.3% |
| 2020 Q2 | 44.84 Million USD | 0.25% |
| 2020 Q3 | 44.44 Million USD | -0.89% |
| 2020 Q4 | 46.2 Million USD | 3.96% |
| 2020 FY | 46.2 Million USD | 7.73% |
| 2019 Q1 | 43.34 Million USD | 2.25% |
| 2019 Q2 | 40.88 Million USD | -5.66% |
| 2019 FY | 42.88 Million USD | 1.17% |
| 2019 Q3 | 41.82 Million USD | 2.29% |
| 2019 Q4 | 42.88 Million USD | 2.53% |
| 2018 Q4 | 42.39 Million USD | -0.61% |
| 2018 FY | 42.39 Million USD | 77.29% |
| 2018 Q3 | 42.65 Million USD | 91.94% |
| 2018 Q2 | 22.22 Million USD | 1.41% |
| 2018 Q1 | 21.91 Million USD | -8.36% |
| 2017 Q4 | 23.9 Million USD | 12.16% |
| 2017 FY | 23.9 Million USD | 22.37% |
| 2017 Q1 | 19.75 Million USD | 1.1% |
| 2017 Q2 | 21.03 Million USD | 6.5% |
| 2017 Q3 | 21.31 Million USD | 1.33% |
| 2016 Q4 | 19.53 Million USD | 11.38% |
| 2016 Q2 | 20.46 Million USD | 7.17% |
| 2016 FY | 19.53 Million USD | 0.21% |
| 2016 Q3 | 17.54 Million USD | -14.3% |
| 2016 Q1 | 19.1 Million USD | -2.04% |
| 2015 Q4 | 19.49 Million USD | 0.32% |
| 2015 Q2 | 10.94 Million USD | 4.0% |
| 2015 Q3 | 19.43 Million USD | 77.65% |
| 2015 FY | 19.49 Million USD | 90.98% |
| 2015 Q1 | 10.51 Million USD | 3.03% |
| 2014 Q3 | 10.1 Million USD | -1.55% |
| 2014 Q4 | 10.2 Million USD | 1.02% |
| 2014 Q2 | 10.26 Million USD | -1.93% |
| 2014 FY | 10.2 Million USD | -11.23% |
| 2014 Q1 | 10.46 Million USD | -8.98% |
| 2013 Q1 | 12.17 Million USD | -1.23% |
| 2013 Q4 | 11.5 Million USD | 1.19% |
| 2013 FY | 11.5 Million USD | -6.73% |
| 2013 Q3 | 11.36 Million USD | -4.81% |
| 2013 Q2 | 11.93 Million USD | -1.97% |
| 2012 Q2 | 13.12 Million USD | -20.39% |
| 2012 Q3 | 12.69 Million USD | -3.27% |
| 2012 Q1 | 16.49 Million USD | -15.29% |
| 2012 FY | 12.33 Million USD | -36.66% |
| 2012 Q4 | 12.33 Million USD | -2.9% |
| 2011 Q4 | 19.46 Million USD | 4.71% |
| 2011 Q2 | 19.34 Million USD | 3.23% |
| 2011 Q1 | 18.74 Million USD | 3.18% |
| 2011 FY | 19.46 Million USD | 7.18% |
| 2011 Q3 | 18.59 Million USD | -3.9% |
| 2010 Q2 | 15.18 Million USD | 4.03% |
| 2010 FY | 18.16 Million USD | 24.33% |
| 2010 Q1 | 14.59 Million USD | -0.08% |
| 2010 Q4 | 18.16 Million USD | 2.42% |
| 2010 Q3 | 17.73 Million USD | 16.78% |
| 2009 Q2 | 12.67 Million USD | 9.87% |
| 2009 Q3 | 13.87 Million USD | 9.45% |
| 2009 Q4 | 14.6 Million USD | 5.3% |
| 2009 FY | 14.6 Million USD | 33.13% |
| 2009 Q1 | 11.53 Million USD | 5.14% |
| 2008 Q4 | 10.97 Million USD | 0.47% |
| 2008 Q3 | 10.92 Million USD | -0.61% |
| 2008 FY | 10.97 Million USD | -5.68% |
| 2008 Q1 | 10.72 Million USD | -7.85% |
| 2008 Q2 | 10.98 Million USD | 2.49% |
| 2007 Q4 | 11.63 Million USD | -3.34% |
| 2007 FY | 11.63 Million USD | -20.54% |
| 2007 Q3 | 12.03 Million USD | -7.32% |
| 2007 Q2 | 12.98 Million USD | -4.22% |
| 2007 Q1 | 13.55 Million USD | -7.4% |
| 2006 FY | 14.64 Million USD | 2.86% |
| 2006 Q1 | 14.74 Million USD | 3.59% |
| 2006 Q3 | 14.69 Million USD | 0.19% |
| 2006 Q4 | 14.64 Million USD | -0.34% |
| 2006 Q2 | 14.66 Million USD | -0.56% |
| 2005 Q1 | 11.9 Million USD | 2.28% |
| 2005 FY | 14.23 Million USD | 22.27% |
| 2005 Q4 | 14.23 Million USD | 8.63% |
| 2005 Q3 | 13.1 Million USD | 6.24% |
| 2005 Q2 | 12.33 Million USD | 3.59% |
| 2004 Q4 | 11.64 Million USD | 11.81% |
| 2004 Q2 | 9.24 Million USD | 13.25% |
| 2004 Q1 | 8.16 Million USD | 13.12% |
| 2004 FY | 11.64 Million USD | 61.29% |
| 2004 Q3 | 10.41 Million USD | 12.61% |
| 2003 FY | 7.21 Million USD | -47.94% |
| 2003 Q1 | 12.51 Million USD | -9.71% |
| 2003 Q3 | 10.97 Million USD | -20.31% |
| 2003 Q2 | 13.77 Million USD | 10.06% |
| 2003 Q4 | 7.21 Million USD | -34.26% |
| 2002 FY | 13.86 Million USD | -20.3% |
| 2002 Q4 | 13.86 Million USD | -18.78% |
| 2002 Q2 | 18.26 Million USD | 3.81% |
| 2002 Q3 | 17.06 Million USD | -6.53% |
| 2002 Q1 | 17.58 Million USD | 1.12% |
| 2001 FY | 17.39 Million USD | 111.16% |
| 2001 Q1 | 8.22 Million USD | -0.11% |
| 2001 Q2 | 9.15 Million USD | 11.31% |
| 2001 Q4 | 17.39 Million USD | 29.3% |
| 2001 Q3 | 13.45 Million USD | 46.88% |
| 2000 Q2 | 7.95 Million USD | 26.86% |
| 2000 FY | 8.23 Million USD | 49.77% |
| 2000 Q1 | 6.26 Million USD | 13.95% |
| 2000 Q3 | 8.59 Million USD | 8.12% |
| 2000 Q4 | 8.23 Million USD | -4.18% |
| 1999 Q1 | 4 Million USD | -2.44% |
| 1999 FY | 5.5 Million USD | 34.15% |
| 1999 Q2 | 4 Million USD | 0.0% |
| 1999 Q3 | 3.8 Million USD | -5.0% |
| 1999 Q4 | 5.5 Million USD | 44.74% |
| 1998 Q3 | 3.8 Million USD | 11.76% |
| 1998 Q1 | 3.7 Million USD | -7.5% |
| 1998 Q2 | 3.4 Million USD | -8.11% |
| 1998 FY | 4.1 Million USD | 2.5% |
| 1998 Q4 | 4.1 Million USD | 7.89% |
| 1997 FY | 4 Million USD | -4.76% |
| 1997 Q1 | 4.2 Million USD | 0.0% |
| 1997 Q4 | 4 Million USD | -24.53% |
| 1997 Q3 | 5.3 Million USD | 20.45% |
| 1997 Q2 | 4.4 Million USD | 4.76% |
| 1996 FY | 4.2 Million USD | 0.0% |
| 1996 Q4 | 4.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 98.858% |
| Addus HomeCare Corporation | 1.02 Billion USD | 94.024% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | 71.332% |
| Amedisys, Inc. | 2.06 Billion USD | 97.028% |
| American Oncology Network, Inc. | 374.45 Million USD | 83.651% |
| Astrana Health, Inc. | 933.36 Million USD | 93.441% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 96.261% |
| IMAC Holdings, Inc. | 1.14 Million USD | -5250.909% |
| biote Corp. | 155.29 Million USD | 60.578% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 90.988% |
| COMPASS Pathways plc | 275.98 Million USD | 77.818% |
| DocGo Inc. | 490.45 Million USD | 87.517% |
| The Ensign Group, Inc. | 4.17 Billion USD | 98.535% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 92.378% |
| InnovAge Holding Corp. | 547.66 Million USD | 88.821% |
| Assure Holdings Corp. | 7.51 Million USD | -714.756% |
| The Joint Corp. | 87.15 Million USD | 29.753% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 97.259% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -670.013% |
| ModivCare Inc. | 1.76 Billion USD | 96.536% |
| NewGenIvf Group Limited | 1.64 Million USD | -3616.07% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -72.147% |
| Option Care Health, Inc. | 3.32 Billion USD | 98.161% |
| P3 Health Partners Inc. | 860.96 Million USD | 92.889% |
| P3 Health Partners Inc. | 860.96 Million USD | 92.889% |
| The Pennant Group, Inc. | 539.69 Million USD | 88.656% |
| Surgery Partners, Inc. | 7.01 Billion USD | 99.128% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -1143.495% |
| Talkspace, Inc. | 142.22 Million USD | 56.954% |
| Talkspace, Inc. | 142.22 Million USD | 56.954% |
| The Oncology Institute, Inc. | 219.41 Million USD | 72.099% |
| The Oncology Institute, Inc. | 219.41 Million USD | 72.099% |